ICON Reaffirms 2024 Outlook, Provides 2025 Guidance; Shares Down Pre-Bell

USA
EnglishUK
EnglishIndia
EnglishAustralia
EnglishCanada
EnglishFrance
FrançaisSuisse
FrançaisEspaña
EspañolDeutschland
DeutschÖsterreich
DeutschSchweiz
DeutschBelgië
NederlandsNederland
NederlandsItalia
ItalianoSverige
Svenska
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
186.21 USD | +1.95% |
|
-3.75% | -11.21% |
02-13 | Truist Securities Adjusts Price Target on ICON to $262 From $284, Keeps Buy Rating | MT |
01-30 | Icon Portfolio of Ai Tools Drives Clinical Trial Efficiencies | CI |